In our study, we demonstrate for the first time that Sal A is a selective ETAR antagonist in both exogenous and endogenous cell lines and reveal the inhibitory effect of Sal A on the proliferation of multiple tumor cell lines. Here, EDNRA is linked to neoplasm.